IO Investigación has acquired GESOP
IO Investigación has acquired a 49% stake in GESOP. This transaction enables IO Investigación to enter the high-growth public administration sector and establish a presence in Catalonia, Spain, where it plans to expand operations and grow its client network in the coming years.
Founded in 1995, IO Investigación is an independent company specializing in market research, panel services, commercial marketing and field force solutions. It serves clients across various sectors, including consumer electronics, telecommunications, financial services, insurance and retail.
GESOP is a Barcelona-based company dedicated to research, social studies and public opinion, with a focus on the public sector.
Oaklins’ team in Spain acted as the financial advisor to the bidder, IO Investigación, on all aspects of the transaction’s execution.
Talk to the deal team
Related deals
Bezeq Online has been acquired by One Software Technologies
Bezeq Online has been acquired by ONE Software Technologies Ltd., enabling ONE Technologies to offer innovative solutions through full integration of advanced technology, real-time data analysis and proven service capabilities nationwide. ONE Technologies’ goal is to develop the next generation of service solutions, including AI-based tools, automation, multi-channel digital services and advanced CRM systems, all designed to deliver a continuous, accurate and effective customer experience.
Learn morePredatech Limited has been acquired by Ekco Group
UK-based cybersecurity consultancy Predatech Limited has been acquired by Ekco Group.
Learn morePropper Daley has been acquired by Bully Pulpit International
Greg Propper’s social impact agency, Propper Daley, has been acquired by strategic communications and public affairs firm Bully Pulpit International (BPI), a portfolio company of Broad Sky Partners. Propper Daley will immediately transition to the BPI brand, with its team of 25 integrating into BPI’s US organizational structure. The agency’s entertainment philanthropy practice will continue to operate independently.
Learn more